Knowing where your donation goes within a nonprofit is very important to understand. And on top of that, it’s important to know how much of your donation is going to the mission. So many donors don’t look into these two key points and then they are baffled to learn...
Below is a follow up from our October 12th blog post. Questions from Georgette’s interview are addressed by our Founder and CEO, Dr. Benedict Benigno… Georgette: Like anyone with a first diagnosis, I was shocked when I learned I had breast cancer. But for ovarian? I...
We’re proud of our Founder, Dr. Benedict Benigno, for his fantastic book review in the current American Society of Clinical Oncology publication! Purchase the second edition by clicking here. Read the review...
So, it’s October. And the breast cancer awareness bus has arrived. Again, if you’ve read previous blogs, I am very clear that all the focus on breast cancer awareness has saved lives. It is working. Those of us with ovarian cancer just feel like it’s time to talk...
Promos and plans are already very visible for the upcoming October Breast Cancer Awareness month. I am confident that the significant focus on breast cancer each October has saved many, many lives. It is important, it impacts 1 in 8 women and early detection (like any...
THE OCI BRAND It seems appropriate that our new brand was released just before Ovarian Cancer Awareness Month… I wish I could say it was on purpose, but it was merely the result of great work from an excellent team. The brand of the Ovarian Cancer Institute...
In my experience, people want to know something about the person who is writing a blog, so that seems the best place to start. My name is Ann Pinyan. I feel like I should follow that up with my birthdate, and then perhaps my Medical Record number, because that’s so...
“It’s not uncommon that the earliest symptom is that ‘My jeans are getting tight and I am not gaining weight.'” See Dr. Benigno in medical waiting rooms all over the country on the Health Media Network....
The Ovarian Cancer Institute, in partnership with Georgia Tech, has developed an a method to detect ovarian cancer that is highly accurate in patients with Stage 1 disease. The study, entitled “Highly-accurate metabolomic detection of early-stage ovarian...
